DGNS: PT Diagnos Laboratorium Utama Tbk - Summary | Jitta

PT Diagnos Laboratorium Utama Tbk

IDN:DGNS

Price
Rp226.00
Loss Chance
49.2%
4.06JITTA SCORE
129.52%Over Jitta Line
Jitta Ranking
525 / 826
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (59)
Recent Business Performance (64)
Financial Strength (63)
Return to Shareholders (9)
Competitive Advantage (40)
Jitta Signs
Revenue and EarningEarning loss detected in 2023
Operating MarginInconsistent
Recent Business PerformanceEarning decline 265.79% in the last quarter (yoy)
CapExVery High
SG&A to SalesIncreasing
Key Stats
Jitta Score
Jitta Line
4.06
129.52%
4.24
711.02%
Health Care Services
5.11
8.44%
COMPANY DESCRIPTION
PT Diagnos Laboratorium Utama Tbk provides health services using laboratories in Indonesia. The company offers laboratory tests comprising hemostasis, hepatitis, autoimmune and rheumatology, tumor markers, toxicology, lipid, allergies, TORCH, diabetes, electrolytes-blood gases, respiratory tract infection, pathology anatomy, neonatal screening, hematology, body fluids, feces, specific proteins, DNAnswer genomics, kidney function, liver function, immunology, osteoporosis, thyroid, pharmacogenomic, heart, reproduction and fertility, microbiology, drug monitoring, lungs, gastrointestinal, nutrition and heavy metals, anemia, and other bacteria; genomics; homecare services; and inspection panel tests. It also provides clinical pathology, anatomical pathology, and microbiology laboratory; and corporate health and research services. PT Diagnos Laboratorium Utama Tbk was founded in 2007 and is headquartered in Jakarta Pusat, Indonesia.